These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17869509)

  • 1. Amino-caprolactam derivatives as gamma-secretase inhibitors.
    Parker MF; Bronson JJ; Barten DM; Corsa JA; Du W; Felsenstein KM; Guss VL; Izzarelli D; Loo A; McElhone KE; Marcin LR; Padmanabha R; Pak R; Polson CT; Toyn JH; Varma S; Wang J; Wong V; Zheng M; Roberts SB
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5790-5. PubMed ID: 17869509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
    Neitzel ML; Aubele DL; Marugg JL; Jagodzinski JJ; Konradi AW; Pleiss MA; Szoke B; Zmolek W; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Bova MP; Hemphill S; Basi G
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3715-20. PubMed ID: 21571529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
    Thompson LA; Liauw AY; Ramanjulu MM; Kasireddy-Polam P; Mercer SE; Maduskuie TP; Glicksman M; Roach AH; Meredith JE; Liu RQ; Combs AP; Higaki JN; Cordell B; Seiffert D; Zaczek RC; Robertson DW; Olson RE
    Bioorg Med Chem Lett; 2006 May; 16(9):2357-63. PubMed ID: 16473009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitors.
    Parker MF; Barten DM; Bergstrom CP; Bronson JJ; Corsa JA; Deshpande MS; Felsenstein KM; Guss VL; Hansel SB; Johnson G; Keavy DJ; Lau WY; Mock J; Prasad CV; Polson CT; Sloan CP; Smith DW; Wallace OB; Wang HH; Williams A; Zheng M
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4432-6. PubMed ID: 17606371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods.
    Yang XG; Lv W; Chen YZ; Xue Y
    J Comput Chem; 2010 Apr; 31(6):1249-58. PubMed ID: 19847781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
    Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
    Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
    Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1.
    Stachel SJ; Coburn CA; Rush D; Jones KL; Zhu H; Rajapakse H; Graham SL; Simon A; Katharine Holloway M; Allison TJ; Munshi SK; Espeseth AS; Zuck P; Colussi D; Wolfe A; Pietrak BL; Lai MT; Vacca JP
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2977-80. PubMed ID: 19409780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional quantitative structure-activity relationship modeling of gamma-secretase inhibitors using molecular field analysis.
    Sammi T; Silakari O; Ravikumar M
    Chem Biol Drug Des; 2008 Feb; 71(2):155-66. PubMed ID: 18221306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship studies of N-arylsulfonyl morpholines as γ-secretase inhibitors.
    Li H; Xu R; Cole D; Clader JW; Greenlee WJ; Nomeir AA; Song L; Zhang L
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6606-9. PubMed ID: 20933414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted 2-oxo-azepane derivatives are potent, orally active gamma-secretase inhibitors.
    Kitas EA; Galley G; Jakob-Roetne R; Flohr A; Wostl W; Mauser H; Alker AM; Czech C; Ozmen L; David-Pierson P; Reinhardt D; Jacobsen H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):304-8. PubMed ID: 17983746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridine-derived γ-secretase modulators.
    Wan Z; Hall A; Sang Y; Xiang JN; Yang E; Smith B; Harrison DC; Yang G; Yu H; Price HS; Wang J; Hawkins J; Lau LF; Johnson MR; Li T; Zhao W; Mitchell WL; Su X; Zhang X; Zhou Y; Jin Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4832-5. PubMed ID: 21742495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors.
    Asberom T; Bara TA; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):205-7. PubMed ID: 17046254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
    Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
    J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel orally active, dibenzazepinone-based gamma-secretase inhibitors.
    Peters JU; Galley G; Jacobsen H; Czech C; David-Pierson P; Kitas EA; Ozmen L
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5918-23. PubMed ID: 17869099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors.
    Parker MF; Barten DM; Bergstrom CP; Bronson JJ; Corsa JA; Dee MF; Gai Y; Guss VL; Higgins MA; Keavy DJ; Loo A; Mate RA; Marcin LR; McElhone KE; Polson CT; Roberts SB; Macor JE
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6828-31. PubMed ID: 23046960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.